BAP1 Mutant Malignant Pleural Mesothelioma (MPM): Outcomes with Chemotherapy, ICPi and PARPi

被引:1
|
作者
Dudnik, E. [1 ]
Bar, J. [2 ]
Kuznetsov, T. [2 ]
Moskovitz, M. [3 ]
Dudnik, J. [4 ]
Shochat, T. [5 ]
Zer, A. [1 ]
Urban, D. [2 ]
机构
[1] Rabin Med Ctr, Davidoff Canc Ctr, Thorac Canc Serv, Petah Tiqwa, Israel
[2] Chaim Sheba Med Ctr, Inst Oncol, Ramat Gan, Israel
[3] Rambam Hlth Care Campus, Thorac Canc Serv, Haifa, Israel
[4] Soroka Univ Med Ctr, Inst Canc, Beer Sheva, Israel
[5] Rabin Med Ctr, Stat Consulting Unit, Petah Tiqwa, Israel
关键词
BAP1; immune check-point inhibitors; poly (ADP-ribose) polymerase inhibitors;
D O I
10.1016/j.jtho.2019.08.1632
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
P2.06-14
引用
收藏
页码:S760 / S760
页数:1
相关论文
共 50 条
  • [21] Germline BAP1 mutations predispose to malignant mesothelioma
    Joseph R Testa
    Mitchell Cheung
    Jianming Pei
    Jennifer E Below
    Yinfei Tan
    Eleonora Sementino
    Nancy J Cox
    A Umran Dogan
    Harvey I Pass
    Sandra Trusa
    Mary Hesdorffer
    Masaki Nasu
    Amy Powers
    Zeyana Rivera
    Sabahattin Comertpay
    Mika Tanji
    Giovanni Gaudino
    Haining Yang
    Michele Carbone
    Nature Genetics, 2011, 43 : 1022 - 1025
  • [22] Germline BAP1 mutations predispose to malignant mesothelioma
    Testa, Joseph R.
    Cheung, Mitchell
    Pei, Jianming
    Below, Jennifer E.
    Tan, Yinfei
    Sementino, Eleonora
    Cox, Nancy J.
    Dogan, A. Umran
    Pass, Harvey I.
    Trusa, Sandra
    Hesdorffer, Mary
    Nasu, Masaki
    Powers, Amy
    Rivera, Zeyana
    Comertpay, Sabahattin
    Tanji, Mika
    Gaudino, Giovanni
    Yang, Haining
    Carbone, Michele
    NATURE GENETICS, 2011, 43 (10) : 1022 - U140
  • [23] BAP1 and miR-31 combination predicts outcome in epithelioid malignant pleural mesothelioma
    Pecci, F.
    Cantini, L.
    Cognigni, V.
    Murrone, A.
    Monaco, F.
    Rubini, C.
    Barbisan, F.
    Copparoni, C.
    Rinaldi, S.
    Fiordoliva, I.
    Paolo, M. Di Pietro
    Scarpelli, M.
    Tomasetti, M.
    Santarelli, L.
    Berardi, R.
    ANNALS OF ONCOLOGY, 2020, 31 : S1080 - S1080
  • [24] Alterations in BAP1 Are Associated with Cisplatin Resistance through Inhibition of Apoptosis in Malignant Pleural Mesothelioma
    Oehl, Kathrin
    Vrugt, Bart
    Wagner, Ulrich
    Kirschner, Michaela B.
    Meerang, Mayura
    Weder, Walter
    Felley-Bosco, Emanuela
    Wollscheid, Bernd
    Bankov, Katrin
    Demes, Melanie C.
    Opitz, Isabelle
    Wild, Peter J.
    CLINICAL CANCER RESEARCH, 2021, 27 (08) : 2277 - 2291
  • [25] BAP1 Deficiency Inflames the TME & is a Candidate Biomarker for Improved Immunotherapy in Malignant Pleural Mesothelioma
    Xu, D.
    Gao, Y.
    Yang, H.
    Marti, T. M.
    Losmanova, T.
    Dorn, P.
    Shu, Y.
    Peng, R.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S164 - S165
  • [26] BAP1 mutation in mesothelioma and "BAP1 Cancer Syndrome"
    Nasu, Masaki
    Napolitano, Andrea
    Pastorino, Sandra
    Tanji, Mika
    Flores, Erin
    Baumann, Francine
    Powers, Amy
    Gaudino, Giovanni
    Pass, Harvey I.
    Yang, Haining
    Carbone, Michele
    CANCER RESEARCH, 2014, 74 (19)
  • [27] LACK OF RESPONSE TO CHEMOTHERAPY FOR PREVIOUSLY TREATED MALIGNANT PLEURAL MESOTHELIOMA (MPM)
    Zauderer, Marjorie G.
    Kass, Samantha L.
    Sima, Camelia S.
    Ginsberg, Michelle S.
    Krug, Lee M.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S638 - S639
  • [28] First line chemotherapy with vinorelbine and cisplatin in malignant pleural mesothelioma (MPM)
    Sorensen, Jens B.
    Frank, Hanna
    Palshof, Torben
    ANNALS OF ONCOLOGY, 2004, 15 : 192 - 193
  • [29] Healthcare Professional Perceptions of Chemotherapy in Treatment of Malignant Pleural Mesothelioma (MPM)
    Kao, Steven
    Dhillon, Haryana
    Warby, Anne
    Vardy, Janette
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S629 - S629
  • [30] BAP1 germline variants in Finnish patients with malignant mesothelioma
    Repo, Pauliina
    Staskiewicz, Aleksandra
    Sutinen, Eva
    Ronty, Mikko
    Kivela, Tero T.
    Myllarniemi, Marjukka
    Turunen, Joni A.
    LUNG CANCER, 2022, 165 : 102 - 107